Gil-Bazo I - Search Results

1

A novel [⁸⁹Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.

Puyalto A, Rodríguez-Remírez M, López I, Iribarren F, Simón JA, Ecay M, Collantes M, Vilalta-Lacarra A, Francisco-Cruz A, Solórzano JL, Sandiego S, Peñuelas I, Calvo A, Ajona D, Gil-Bazo I. Puyalto A, et al. Among authors: gil bazo i. Front Immunol. 2023 Sep 28;14:1272570. doi: 10.3389/fimmu.2023.1272570. eCollection 2023. Front Immunol. 2023. PMID: 37841258 Free PMC article.

2

Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.

Bosch-Barrera J, Gil-Bazo I. Bosch-Barrera J, et al. Lung Cancer. 2011 Feb;71(2):244; author reply 245. doi: 10.1016/j.lungcan.2010.10.004. Epub 2010 Nov 4. Lung Cancer. 2011. PMID: 21055842 No abstract available.

3

Pneumomediastinum as a complication of SABR for lung metastases.

Rodríguez-Ruiz ME, Arévalo E, Gil-Bazo I, Olarte García A, Valtueña G, Moreno-Jiménez M, Arbea-Moreno L, Aristu J. Rodríguez-Ruiz ME, et al. Radiat Oncol. 2015 Jan 23;10:25. doi: 10.1186/s13014-015-0330-y. Radiat Oncol. 2015. PMID: 25612575 Free PMC article.

4

Unresectable liver metastases from colorectal cancer and hepatic arterial infusion chemotherapy: how, when and to whom?

Viúdez A, Rodríguez J, Gil-Bazo I. Viúdez A, et al. Cardiovasc Intervent Radiol. 2009 May;32(3):603-4. doi: 10.1007/s00270-009-9514-x. Epub 2009 Feb 5. Cardiovasc Intervent Radiol. 2009. PMID: 19194743 No abstract available.

5

Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.

Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, Martínez-García M, Millastre E, Aparisi F, Navarro M, Dómine M, Gil-Bazo I, Pérez Segura P, Gil M, Bruna J. Subirá D, et al. Neuro Oncol. 2012 Jan;14(1):43-52. doi: 10.1093/neuonc/nor172. Epub 2011 Oct 12. Neuro Oncol. 2012. PMID: 21993441 Free PMC article.

6

Nonconvulsive status epilepticus related to posterior reversible leukoencephalopathy syndrome induced by cetuximab.

Palma JA, Gomez-Ibañez A, Martin B, Urrestarazu E, Gil-Bazo I, Pastor MA. Palma JA, et al. Neurologist. 2011 Sep;17(5):273-5. doi: 10.1097/NRL.0b013e3182173655. Neurologist. 2011. PMID: 21881470

7

Enzalutamide in metastatic prostate cancer before chemotherapy.

Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.

8

Novel translational strategies in colorectal cancer research.

Gil-Bazo I. Gil-Bazo I. World J Gastroenterol. 2007 Nov 28;13(44):5902-10. doi: 10.3748/wjg.v13.i44.5902. World J Gastroenterol. 2007. PMID: 17990355 Free PMC article. Review.

9

Targeting hypoxia and angiogenesis through HIF-1alpha inhibition.

Diaz-Gonzalez JA, Russell J, Rouzaut A, Gil-Bazo I, Montuenga L. Diaz-Gonzalez JA, et al. Cancer Biol Ther. 2005 Oct;4(10):1055-62. doi: 10.4161/cbt.4.10.2195. Epub 2005 Oct 21. Cancer Biol Ther. 2005. PMID: 16294030 Review.

10

Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody.

Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen JJ, Zhao Y, Chao S, Cheong W, Ke Y, Al-Ahmadie H, Gerald WL, Brogi E, Benezra R. Perk J, et al. Cancer Res. 2006 Nov 15;66(22):10870-7. doi: 10.1158/0008-5472.CAN-06-2643. Cancer Res. 2006. PMID: 17108123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page